Starling Oncology, Inc. SEC filings DFPH

Starling Oncology, Inc. has 544 filings in SEC EDGAR's recent list, going back to Jan 14, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Starling Oncology, Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
10-K Annual report Mar 12, 2026 Dec 31, 2025
ARS Annual report to shareholders Mar 26, 2025 Dec 31, 2024
10-K Annual report Mar 26, 2025 Dec 31, 2024
10-K/A Amended annual report May 22, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
10-K/A Amended annual report Apr 22, 2024 Dec 31, 2023
10-K Annual report Mar 28, 2024 Dec 31, 2023
10-K Annual report Mar 16, 2023 Dec 31, 2022
10-K Annual report Mar 11, 2022 Dec 31, 2021
10-K/A Amended annual report Dec 14, 2021 Dec 31, 2020
10-K/A Amended annual report May 24, 2021 Dec 31, 2020
10-K Annual report Mar 30, 2021 Dec 31, 2020

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
STLN (Nasdaq), DFPH (OTC), STLNW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cerritos, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1799191
Former names
Oncology Institute, Inc. (until Aug 3, 2026); DFP HEALTHCARE ACQUISITIONS CORP. (until Nov 12, 2021)

Other Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.